As the number of cases of a rare, noncontagious form of meningitis grow, some facilities that treat workers compensation claimants are identified as having received tainted medications.
An article on BusinessInsurance.com has reported that some of these facilities are on a list provided by the Centers for Disease Control and Prevention (CDC) because they received methylprednisolon acetate from New England Compounding Center in Framingham, MA. There is a link between the injectable steroid medication that the company produces and the recent meningitis outbreak. The CDC says that there is still not enough evidence to determine the original source of the outbreak. New England Compounding has recalled products compounded and distributed from its facility.
A list of the facilities that received lots of the recalled medication is available on the CDC website.